Ignite Creation Date:
2024-05-06 @ 7:59 AM
Last Modification Date:
2024-10-26 @ 11:55 AM
Study NCT ID:
NCT02648243
Status:
COMPLETED
Last Update Posted:
2021-03-10
First Post:
2016-01-03
Brief Title:
Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar
Sponsor:
Qatar University
Organization:
Qatar University
Study Overview
Official Title:
Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In Qatar cardiovascular diseases CVD have become the leading cause of morbidity and mortality over the past two decades Between 1991 and 2010 a total of 16736 patients were admitted with ACS Acute Coronary Syndrome in Qatar Despite the use of percutaneous coronary intervention PCI coronary artery bypass graft CABG and pharmacological agents to acutely reduce vascular risk ACS patients are at high risk of having further cardiovascular events Consequently secondary cardiovascular risk reduction therapy is needed for all CAD Coronary Artery Disease patients Clinical practice guidelines recommend that following ACS patients should receive indefinite treatment with aspirin a beta blocker an angiotensin converting enzyme inhibitor ACEI or alternatively angiotensin II receptor blocker ARB and a statin Less than 80 of ACS patients in Qatar use this quadruple combination after discharge This creates a significant opportunity for pharmacists to improve CVD management and outcomes in Qatar Nothing is known about the impact of Qatar clinical pharmacists as direct patient-care team members at discharge and post-discharge on the short-term and long-term outcomes of ACS patients The proposed study is aimed to determine this impact The investigators hypothesize that a clinical pharmacist-delivered intervention consisting of medication reconciliation and counseling at discharge and tailored follow-up post-discharge will decrease hospital readmissions emergency department ED visits and all-cause mortality at 3 month 6 months and 12 months after hospital discharge when compared with control arm and pharmacist delivered intervention at discharge only among ACS patients The investigators also hypothesize that the effect of the intervention will increase patients adherence to evidence-based secondary prevention medications for CAD Coronary Artery Disease and patient satisfaction with pharmacy services Besides this intervention will reduce the treatment burden on patients
Detailed Description:
Nothing is known about the impact of Qatar clinical pharmacists as direct patient-care team members at discharge and post-discharge on the short-term and long-term outcomes of patients with ACS at Heart Hospital in Qatar This research project aims to determine this
The investigators hypothesize that a clinical pharmacist-delivered intervention consisting of medication reconciliation and counseling at discharge and tailored follow-up post-discharge will decrease hospital readmissions emergency department ED visits and all-cause mortality at 3 months 6 months and 12 months after hospital discharge when compared with control arm and pharmacist delivered intervention at discharge only among ACS patients The investigators also hypothesize that the effect of the intervention will increase patients adherence to evidence-based secondary prevention medications for CAD and patient satisfaction with pharmacy services besides this intervention will reduce the treatment burden on patients
Study objectives
1 To evaluate the effectiveness of clinical pharmacist-delivered intervention at discharge and tailored follow-up post-discharge on decreasing hospital readmissions ED visits and mortality in ACS patients
2 To evaluate the effectiveness of the intervention on improving patient adherence to evidence-based secondary prevention CAD medications
3 To study the effect of the intervention on reducing the burden of treatment on patients
4 To assess the effect of the intervention on increasing patient satisfaction with pharmacy services at Heart Hospital in Qatar
The investigators hypothesize that a clinical pharmacist-delivered intervention consisting of medication reconciliation and counseling at discharge and tailored follow-up post-discharge will decrease hospital readmissions emergency department ED visits and all-cause mortality at 3 months 6 months and 12 months after hospital discharge when compared with control arm and pharmacist delivered intervention at discharge only among ACS patients The investigators also hypothesize that the effect of the intervention will increase patients adherence to evidence-based secondary prevention medications for CAD and patient satisfaction with pharmacy services besides this intervention will reduce the treatment burden on patients
Study objectives
1 To evaluate the effectiveness of clinical pharmacist-delivered intervention at discharge and tailored follow-up post-discharge on decreasing hospital readmissions ED visits and mortality in ACS patients
2 To evaluate the effectiveness of the intervention on improving patient adherence to evidence-based secondary prevention CAD medications
3 To study the effect of the intervention on reducing the burden of treatment on patients
4 To assess the effect of the intervention on increasing patient satisfaction with pharmacy services at Heart Hospital in Qatar
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None